Literature DB >> 28471539

Sokolow-Lyon voltage is suitable for monitoring improvement in cardiac function and prognosis of patients with idiopathic dilated cardiomyopathy.

Kenji Fukaya1, Kyosuke Takeshita1,2, Takahiro Okumura1, Hiroaki Hiraiwa1, Soichiro Aoki1, Takeo Ichii1, Yuki Sugiura1, Katsuhide Kitagawa1, Toru Kondo1, Naoki Watanabe1, Naoaki Kano1, Kenji Furusawa1, Akinori Sawamura1, Ryota Morimoto1, Yasuko Bando1, Toyoaki Murohara1.   

Abstract

BACKGROUND: The clinical significance of electrocardiogram in the assessment of patients with idiopathic dilated cardiomyopathy (IDCM) is currently unknown. The aim of this study was to determine the feasibility of recording serial changes in Sokolow-Lyon voltage (∆%QRS-voltage) in one year to estimate left ventricular reverse remodeling (LVRR) and predict a prognosis of IDCM patients under tailored medical therapy.
METHODS: Sixty-eight consecutive patients with mild symptoms (52.1 ± 13 years old; 69% men; NYHA I/II/III/IV; 33/29/6/0) underwent electrocardiography and echocardiography at baseline and 12 month follow-up (follow-up period: 3.9 years).
RESULTS: LVRR was observed in 30 patients (44.1%). The ∆%QRS-voltage was significantly lower in the LVRR group (LVRR; -26.9%, non-LVRR: -9.2%, p < .001). Univariate analysis showed that ∆%QRS-voltage correlated with ∆%LV end-diastolic diameter (r = .634, p < .001), and with ∆%LV ejection fraction and ∆%LV mass index (r = -.412, p < .001; r = .429, p < .001 respectively). Using receiver operating characteristic curve analysis for the estimation of LVRR, ∆%QRS of -14.7% showed optimal sensitivity (63.2%) and specificity (83.3%) (AUC = 0.775, p < .001). The composite endpoints of cardiac death (n = 0), hospitalization for advanced heart failure (n = 11) and fatal arrhythmia (n = 2) were observed in 13 patients during the follow-up period. Kaplan-Meier analysis showed significantly higher event-free rate in patients of the low ∆%QRS-voltage group (<-14.7%) (83%) than those of the high group (66%, p = .022).
CONCLUSIONS: The present study showed that decrease in Sokolow-Lyon voltage is associated with improvement in cardiac function and favorable prognosis in IDCM patients on medical therapy, suggesting that this index is a feasible marker for response to treatment of IDCM.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Sokolow-Lyon voltage; dilated cardiomyopathy; electrocardiography; left ventricular reverse remodeling; prognosis

Mesh:

Year:  2017        PMID: 28471539      PMCID: PMC6931852          DOI: 10.1111/anec.12431

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  25 in total

1.  Study of the transmembrane action potential, electrogram, electrocardiogram and vectorcardiogram of rats with left ventricular hypertrophy.

Authors:  H N UHLEY
Journal:  Am J Cardiol       Date:  1961-02       Impact factor: 2.778

Review 2.  Improving Appropriateness and Quality in Cardiovascular Imaging: A Review of the Evidence.

Authors:  Sanjeev Bhattacharyya; Guy Lloyd
Journal:  Circ Cardiovasc Imaging       Date:  2015-12       Impact factor: 7.792

3.  Demonstration of the relationship between heart dimensions and QRS voltage amplitude.

Authors:  D Castini; E Vitolo; M Ornaghi; F Gentile
Journal:  J Electrocardiol       Date:  1996-07       Impact factor: 1.438

4.  A critical appraisal of the electrocardiographic criteria for the diagnosis of left ventricular hypertrophy.

Authors:  D W Romhilt; K E Bove; R J Norris; E Conyers; S Conradi; D T Rowlands; R C Scott
Journal:  Circulation       Date:  1969-08       Impact factor: 29.690

Review 5.  Idiopathic dilated cardiomyopathy.

Authors:  G W Dec; V Fuster
Journal:  N Engl J Med       Date:  1994-12-08       Impact factor: 91.245

6.  Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.

Authors:  Eri Hoshikawa; Yoshihisa Matsumura; Toru Kubo; Makoto Okawa; Naohito Yamasaki; Hiroaki Kitaoka; Takashi Furuno; Jun Takata; Yoshinori L Doi
Journal:  Am J Cardiol       Date:  2011-02-04       Impact factor: 2.778

7.  Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment.

Authors:  Marco Merlo; Stylianos A Pyxaras; Bruno Pinamonti; Giulia Barbati; Andrea Di Lenarda; Gianfranco Sinagra
Journal:  J Am Coll Cardiol       Date:  2011-03-29       Impact factor: 24.094

8.  Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease.

Authors:  Paolo Verdecchia; Peter Sleight; Giuseppe Mancia; Robert Fagard; Bruno Trimarco; Roland E Schmieder; Jae-Hyung Kim; Garry Jennings; Petr Jansky; Jyh-Hong Chen; Lisheng Liu; Peggy Gao; Jeffrey Probstfield; Koon Teo; Salim Yusuf
Journal:  Circulation       Date:  2009-09-21       Impact factor: 29.690

9.  Prevalence and natural history of electrocardiographic left ventricular hypertrophy.

Authors:  W B Kannel
Journal:  Am J Med       Date:  1983-09-26       Impact factor: 4.965

Review 10.  The prognostic value of the ECG in hypertension: where are we now?

Authors:  Dsc Ang; Cc Lang
Journal:  J Hum Hypertens       Date:  2008-04-24       Impact factor: 3.012

View more
  2 in total

1.  Assessment of abdominal aortic calcification by computed tomography for prediction of latent left ventricular stiffness and future cardiovascular risk in pre-dialysis patients with chronic kidney disease: A single center cross-sectional study.

Authors:  Kenji Furusawa; Kyosuke Takeshita; Susumu Suzuki; Yosuke Tatami; Ryota Morimoto; Takahiro Okumura; Yoshinari Yasuda; Toyoaki Murohara
Journal:  Int J Med Sci       Date:  2019-06-07       Impact factor: 3.738

2.  A clinical score for predicting left ventricular reverse remodelling in patients with dilated cardiomyopathy.

Authors:  Yuki Kimura; Takahiro Okumura; Ryota Morimoto; Shingo Kazama; Naoki Shibata; Hideo Oishi; Takashi Araki; Takashi Mizutani; Tasuku Kuwayama; Hiroaki Hiraiwa; Toru Kondo; Toyoaki Murohara
Journal:  ESC Heart Fail       Date:  2021-01-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.